St Jude gets US nod to add V-V (ventricle to ventricle) timing in CRT-Ds (cardiac resynchronisation therapy devices):
This article was originally published in Clinica
Executive Summary
The US FDA has given St Jude Medical approval to add V-V (ventricle to ventricle) timing to new models of its Epic HF and Atlas+ HF family of cardiac resynchronisation therapy devices (CRT-Ds). V-V timing refers to the delay between contraction of the left and right ventricles, compared with simultaneous pulses to both ventricles. St Jude's V-V timing allows physicians to adjust the delay between ventricular outputs, and choose which chamber is paced first. Patients who do not respond to simultaneous biventricular pacing systems may benefit from the sequential timing offered by V-V programmability, said the St Paul, Minnesota firm, which believes it is the first CRT-D supplier in the US to offer this expanded programmability.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.